TMO - Thermo Fisher Scientific Inc.
Close
615.07
3.390 0.551%
Share volume: 1,058,514
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$611.68
3.39
0.55%
View ratios
| Fiscal Date | 2022-10-01 | 2022-12-31 | 2023-04-01 | 2023-07-01 | 2023-09-30 | 2023-12-31 | 2024-03-30 | 2024-06-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-04 | 2023-02-23 | 2023-05-05 | 2023-08-04 | 2023-11-03 | 2024-02-22 | 2024-05-03 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 90.536 B | 97.154 B | 94.658 B | 94.105 B | 97.057 B | 98.726 B | 97.096 B | 98.497 B | |
| Current Assets | 19.299 B | 25.229 B | 20.209 B | 19.995 B | 23.092 B | 24.589 B | 23.640 B | 25.476 B | |
| Inventories | 5.722 B | 5.634 B | 5.664 B | 5.655 B | 5.404 B | 5.088 B | 5.133 B | 5.198 B | |
| Other Current Assets | 2.987 B | 2.956 B | 3.141 B | 3.188 B | 3.167 B | 3.203 B | 3.326 B | 3.512 B | |
| Short Term Investments | 2.987 B | 2.956 B | 3.141 B | 3.188 B | 3.167 B | 3.203 B | 3.326 B | 3.512 B | |
| Total Receivables | 7.671 B | 8.115 B | 7.922 B | 8.019 B | 8.370 B | 8.221 B | 7.931 B | 7.943 B | |
| Current Cash | 2.919 B | 8.524 B | 3.482 B | 3.133 B | 6.151 B | 8.077 B | 7.250 B | 8.823 B | |
| Total Non-current Assets | 71.237 B | 71.925 B | 74.449 B | 74.110 B | 73.965 B | 74.137 B | 73.456 B | 73.021 B | |
| Property Plant Equipment | 8.628 B | 9.280 B | 9.354 B | 9.292 B | 9.167 B | 9.448 B | 9.324 B | 9.282 B | |
| Other Assets | 4.308 B | 4.007 B | 3.983 B | 4.108 B | 4.124 B | 3.999 B | 4.241 B | 4.377 B | |
| Intangible Assets | 17.813 B | 17.442 B | 17.972 B | 17.437 B | 17.091 B | 16.670 B | 16.048 B | 15.519 B | |
| Goodwill | 40.488 B | 41.196 B | 43.140 B | 43.273 B | 43.583 B | 44.020 B | 43.843 B | 43.843 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 90.536 B | 97.154 B | 94.658 B | 94.105 B | 97.057 B | 98.726 B | 97.096 B | 98.497 B | |
| Total liabilities | 46.987 B | 53.176 B | 52.401 B | 50.353 B | 51.729 B | 51.991 B | 51.579 B | 51.067 B | |
| Total current liabilities | 11.118 B | 17.010 B | 15.884 B | 14.112 B | 14.158 B | 14.012 B | 13.937 B | 14.773 B | |
| Accounts Payable | 2.471 B | 3.381 B | 2.798 B | 2.423 B | 2.508 B | 2.872 B | 2.555 B | 2.547 B | |
| Other liabilities | 4.401 B | 4.238 B | 4.230 B | 4.042 B | 4.326 B | 4.642 B | 4.567 B | 4.391 B | |
| Current long term debt | 1.010 B | 5.579 B | 6.122 B | 4.814 B | 4.795 B | 3.609 B | 4.451 B | 5.121 B | |
| Long term debt | 28.150 B | 28.909 B | 29.135 B | 29.194 B | 30.489 B | 31.308 B | 31.157 B | 30.284 B | |
| Other liabilities | 4.401 B | 4.238 B | 4.230 B | 4.042 B | 4.326 B | 4.642 B | 4.567 B | 4.391 B | |
| Minority interest | 178.000 M | 170.000 M | 176.000 M | 163.000 M | 136.000 M | 107.000 M | 107.000 M | 103.000 M | |
| Total Shareholder equity | 43.549 B | 43.978 B | 42.257 B | 43.752 B | 45.328 B | 46.735 B | 45.517 B | 47.432 B | |
| Common stock | 392.000 M | 392.000 M | 386.000 M | 386.000 M | 386.000 M | 386.000 M | 382.000 M | 382.000 M | |
| Retained earnings | 40.452 B | 41.910 B | 43.064 B | 44.289 B | 45.869 B | 47.364 B | 48.542 B | 49.940 B |